Author details

Full Name

Jianfeng Xu

Affiliation

ORCID

Career Start Year

1995

Papers

460

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36781323	Association of Reported Candidate Monogenic Genes With Lung Cancer Risk.	Clin Lung Cancer	2023
37900992	Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort.		2023
37560999	Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes.	J Clin Endocrinol Metab	2023
37334598	Refining Risk for Alzheimer's Disease Among Heterozygous APOEÉ¿4 Carriers.	J Alzheimers Dis	2023
36816149	Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.		2023
36567534	Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry.	Prostate	2023
36752203	Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer.	JCI Insight	2023
36872133	Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.	Eur Urol	2023
37311464	Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.	Am J Hum Genet	2023
37358249	Association of sickle cell trait with adverse pregnancy outcomes in a population-based cohort.		2023
36926049	Assessing the performance of genetic risk score for stratifying risk of post-sepsis cardiovascular complications.		2023
37292833	Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.	medRxiv	2023
37419004	Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort.	Thromb Res	2023
34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	HGG Adv	2022
35461807	Sickle Cell Trait and Risk for Common Diseases: Evidence from the UK Biobank.	American Journal of Medicine	2022
35452513	Identifying Phased Mutations and Complex Rearrangements in Human Prostate Cancer Cell Lines through Linked-Read Whole-Genome Sequencing.	Mol Cancer Res	2022
36353656	Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.	Eur Urol Open Sci	2022
36353071	Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer.	Eur Urol Open Sci	2022
36275420	Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk.	Int J Cardiol Heart Vasc	2022
36076102	Identification of 14 novel susceptibility loci for diaphragmatic hernia development and their biological and clinical implications: results from the UK Biobank.	Surgical Endoscopy and Other Interventional Techniques	2022
36208030	Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohort.	Endocrinol Diabetes Metab	2022
36055957	Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice.	European Urology Focus	2022
36590722	Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non-small cell lung cancer.		2022
33443076	Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.	J Med Genet	2022
34799695	The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.	Br J Cancer	2022
35333400	Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.	Cancer	2022
34674288	Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis.	Prostate	2022
35031163	A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.	Eur Urol	2022
35149774	KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.	Prostate Cancer Prostatic Dis	2022
35347252	Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies.	Prostate Cancer Prostatic Dis	2022
33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
34129519	Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank.	American Journal of Tropical Medicine and Hygiene	2021
33484075	Adiponectin affects estimated glomerular filtration rate: A two-sample bidirectional Mendelian randomization study.	Nephrology	2021
33482857	Assessing the clinical utility of genetic risk scores for targeted cancer screening.	Journal of Translational Medicine	2021
33958727	Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors.	Oncogene	2021
33956350	Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.	Prostate	2021
33579203	Polygenic risk score is a predictor of adenomatous polyps at screening colonoscopy.	BMC Gastroenterology	2021
33473200	Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
34210494	Germline Testing for Prostate Cancer Prognosis: Implications for Active Surveillance.	Urologic Clinics of North America	2021
34210485	Prostate Cancer Predisposition.	Urol Clin North Am	2021
33724955	Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.	JCI Insight	2021
33564077	Correction to: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors.	Oncogene	2021
34254341	Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.	Prostate	2021
34337532	Genetic Susceptibility for Low Testosterone in Men and Its Implications in Biology and Screening: Data from the UK Biobank.	Eur Urol Open Sci	2021
34024654	Incorporation of Polygenic Risk Score into Guidelines for Inherited Risk Assessment for Prostate Cancer.	Eur Urol	2021
33257031	Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.	Eur Urol	2021
33300603	Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.	Int J Cancer	2021
32749611	Somatic DNA copy number alterations in non-dysplastic Barrett's esophagus.	Surgical Endoscopy and Other Interventional Techniques	2021
32800727	Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.	Eur Urol	2021
31042581	Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha.	Clin Gastroenterol Hepatol	2020